- Report
- July 2025
- 250 Pages
Global
From €5226EUR$5,850USD£4,536GBP
- Report
- July 2025
- 179 Pages
Global
From €5226EUR$5,850USD£4,536GBP
- Report
- July 2025
- 193 Pages
Global
From €5226EUR$5,850USD£4,536GBP
- Report
- July 2025
- 100 Pages
Global
From €5226EUR$5,850USD£4,536GBP
- Report
- June 2025
- 189 Pages
Global
From €3417EUR$3,825USD£2,966GBP
€4020EUR$4,500USD£3,489GBP
- Report
- April 2025
- 185 Pages
Global
From €3417EUR$3,825USD£2,966GBP
€4020EUR$4,500USD£3,489GBP
- Report
- January 2025
- 180 Pages
Global
From €3417EUR$3,825USD£2,966GBP
€4020EUR$4,500USD£3,489GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,163GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,163GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,163GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,163GBP
- Clinical Trials
- April 2025
- 50 Pages
Global
From €1340EUR$1,500USD£1,163GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£969GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£969GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1117EUR$1,250USD£969GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1117EUR$1,250USD£969GBP
- Report
- May 2025
- 112 Pages
Global
From €4243EUR$4,750USD£3,683GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2491EUR$2,789USD£2,163GBP
- Report
- June 2025
- 89 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- January 2025
- 210 Pages
Global
From €4462EUR$4,995USD£3,873GBP

Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs.
The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more